CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Why has trade on the Clover Health share price been so volatile?

The Clover Health share price is down 50% year to date as the company finds itself under a SEC investigation and loses SPAC appeal.

Who is Clover Health Investments Corporation?

Clover Health Investments Corp, is a healthcare technology company providing medicare advantage (MA) insurance plans to seniors. The groups offering includes hospital coverage, doctor visits, drug coverage, vision, dental, and hearing coverage.

The group also offers a software platform called the Clover Assistant, provide American seniors with highly affordable, 'obvious' healthcare plans. The company’s flagship software provides physicians with data-driven, personalised insights at the point of care.

Is Clover Health a SPAC?

Clover’s listed debut was through a merger with special purpose acquisition company (SPAC) Social Capital Hedosophia Holdings Corp III late in 2020

Why has the Clover Health share price under pressure?

A share price surge in the middle of the year (2021) appears to have dovetailed with moves in so called ‘meme’ and ‘SPAC’ stocks. The unprecedented gains can largely be attributed to speculative investments from retail traders coordinated on forums such as Reddit (WallStreetBets). These short term gains were however quickly unwound.

The Clover Health share price is down more than 50% year to date (as of 21 July 2021). The company boasts exciting propositions to help better a widely criticised US healthcare system, although the group remains unprofitable at present.

While the company originally forecast ambitious membership numbers in 2021, these numbers have been revised lower as the year has progressed. Clover Health is now also under investigation by the US Securities and Exchange Commission (SEC) on allegations that the company and its promoter, Chamath Palihapitiya, misled investors while promoting the business.

Clover Health share price – technical analysis

The share price of Clover Health has been in a sharp downtrend since June this year. The aggressive decline now sees its historical low at 6.20 as the next support target from the move. The Stochastic labouring in oversold territory is suggestive that short-term traders should not look to bet on a rebound just yet from current levels. Traders hoping for a rebound might prefer to see the price at least starting to trade above the dotted trend line on our chart, accompanied by a sharp move out of oversold territory.

Summary

  • Clover Health is a healthcare technology company providing MA insurance plans to seniors
  • The group also offers a software platform called the Clover Assistant, provide American seniors with highly affordable, ‘obvious’ healthcare plans
  • Clover’s listed debut was through a merger with SPAC Social Capital Hedosophia Holdings Corp III late in 2020
  • The unprecedented gains mid-year can largely be attributed to speculative investments from retail traders coordinated on forums such as Reddit (WallStreetBets)
  • The share price is down more than 50% year to date (as of 21 July 2021)
  • Clover is under investigation by the SEC on allegations that the company and its promoter, Chamath Palihapitiya, misled investors
  • The share price has been in a sharp downtrend since June 2021

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.